These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11220669)

  • 1. Selection and validation of biomarkers for chemoprevention: the contribution of epidemiology.
    Vineis P; Veglia F
    IARC Sci Publ; 2001; 154():57-68. PubMed ID: 11220669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
    Kensler TW; Groopman JD
    J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological relevance of adduct detection to the chemoprevention of cancer.
    Sharma RA; Farmer PB
    Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
    Farmer PB; Singh R
    Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
    Farmer PB
    IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogen-DNA adducts as a biomarker for cancer risk.
    Rundle A
    Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology.
    Wild CP; Pisani P
    IARC Sci Publ; 1997; (142):143-58. PubMed ID: 9354917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention.
    Baird WM; Mahadevan B
    Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adducts as markers of exposure and risk.
    Phillips DH
    Mutat Res; 2005 Sep; 577(1-2):284-92. PubMed ID: 15922369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macromolecular adducts and related biomarkers in biomonitoring and epidemiology of complex exposures.
    Perera F; Jeffrey A; Santella RM; Brenner D; Mayer J; Latriano L; Smith S; Young TL; Tsai WY; Hemminki K
    IARC Sci Publ; 1990; (104):164-80. PubMed ID: 2228114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
    Hecht SS
    IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular approach in cancer epidemiology: early detection of carcinogen-induced mutations in a whole genome (Review).
    Burnouf D; Miturski R; Nagao M; Nakagama H; Nothisen M; Wagner J; Fuchs RP
    Int J Mol Med; 2000 Jan; 5(1):15-20. PubMed ID: 10601568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenge assay: A functional biomarker for exposure-induced DNA repair deficiency and for risk of cancer.
    Au WW; Giri AK; Ruchirawat M
    Int J Hyg Environ Health; 2010 Jan; 213(1):32-9. PubMed ID: 19818682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulky DNA adducts and breast cancer risk in the prospective EPIC-Italy study.
    Saieva C; Peluso M; Masala G; Munnia A; Ceroti M; Piro S; Sera F; Bendinelli B; Pala V; Sieri S; Tumino R; Giurdanella MC; Panico S; Mattiello A; Vineis P; Polidoro S; Matullo G; Palli D
    Breast Cancer Res Treat; 2011 Sep; 129(2):477-84. PubMed ID: 21452020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers.
    Pluygers EP
    Med Lav; 1995; 86(3):278-83. PubMed ID: 7565293
    [No Abstract]   [Full Text] [Related]  

  • 20. Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge.
    Anderson LM
    Mutat Res; 2006 Sep; 608(2):136-56. PubMed ID: 16829162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.